• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哌甲酯显著减少了注意力缺陷多动障碍(ADHD)患者在公路驾驶过程中的注意力不集中情况。

Methylphenidate significantly reduces lapses of attention during on-road highway driving in patients with ADHD.

作者信息

Verster Joris C, Roth Thomas

机构信息

From the *Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; †Centre for Human Psychopharmacology, Swinburne University, Melbourne, Victoria, Australia; and ‡Sleep Disorders and Research Center, Henry Ford Health System, Detroit, MI.

出版信息

J Clin Psychopharmacol. 2014 Oct;34(5):633-6. doi: 10.1097/JCP.0000000000000174.

DOI:10.1097/JCP.0000000000000174
PMID:24978156
Abstract

Lapses of attention are characteristic for attention-deficit/hyperactivity disorder (ADHD) and as such may impair performance of daily activities. Data from an on-road driving study were reanalyzed to determine lapses in patients with ADHD after treatment with methylphenidate and placebo.A total of 18 adult ADHD patients performed a 100-km on-road driving test and were instructed to drive with a steady lateral position and constant speed. The SD of lateral position (SDLP), that is, the weaving of the car, lapses, and alertness, was assessed.Driving was significantly better (P = 0.006) with methylphenidate (SDLP, 18.8 cm) when compared with placebo (SDLP, 21.2 cm). Both the reduction in SDLP and the number of lapses (P = 0.003) confirm this significant improvement, which is further supported by subjective assessments of perceived driving performance. Although lapses were common in the placebo condition (11/18 patients), they were much less frequently observed (5/18 patients) after treatment with methylphenidate. Postdriving assessments suggest that lapses often go unnoticed by drivers.In conclusion, methylphenidate significantly improves driving of patients with ADHD by significantly reducing the number of lapses.

摘要

注意力不集中是注意力缺陷多动障碍(ADHD)的特征,因此可能会影响日常活动的表现。对一项道路驾驶研究的数据进行重新分析,以确定使用哌甲酯和安慰剂治疗后ADHD患者的注意力不集中情况。共有18名成年ADHD患者进行了100公里的道路驾驶测试,并被要求保持稳定的横向位置和恒定的速度行驶。评估了横向位置的标准差(SDLP),即汽车的摆动、注意力不集中情况和警觉性。与安慰剂(SDLP为21.2厘米)相比,使用哌甲酯时驾驶情况明显更好(P = 0.006)(SDLP为18.8厘米)。SDLP的降低和注意力不集中的次数(P = 0.003)都证实了这一显著改善,对驾驶表现的主观评估进一步支持了这一点。尽管在安慰剂组中注意力不集中很常见(11/18患者),但在使用哌甲酯治疗后观察到的情况要少得多(5/18患者)。驾驶后评估表明,驾驶员往往没有注意到注意力不集中的情况。总之,哌甲酯通过显著减少注意力不集中的次数,显著改善了ADHD患者的驾驶情况。

相似文献

1
Methylphenidate significantly reduces lapses of attention during on-road highway driving in patients with ADHD.哌甲酯显著减少了注意力缺陷多动障碍(ADHD)患者在公路驾驶过程中的注意力不集中情况。
J Clin Psychopharmacol. 2014 Oct;34(5):633-6. doi: 10.1097/JCP.0000000000000174.
2
Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial.哌甲酯显著改善成人注意力缺陷多动障碍患者的驾驶表现:一项随机交叉试验。
J Psychopharmacol. 2008 May;22(3):230-7. doi: 10.1177/0269881107082946.
3
Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.与缓释混合安非他明盐相比,使用盐酸哌甲酯控释片进行兴奋剂治疗对改善患有注意力缺陷多动障碍的青少年驾驶员驾驶性能的相对益处。
Pediatrics. 2006 Sep;118(3):e704-10. doi: 10.1542/peds.2005-2947.
4
Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder.控释型哌甲酯可改善患有注意力缺陷多动障碍青少年的道路驾驶注意力。
J Am Board Fam Pract. 2004 Jul-Aug;17(4):235-9. doi: 10.3122/jabfm.17.4.235.
5
ADHD, methylphenidate and driving: does some legislation endanger public health?注意力缺陷多动障碍、哌甲酯与驾驶:某些立法会危及公众健康吗?
J Psychopharmacol. 2008 May;22(3):227-9. doi: 10.1177/0269881108091878.
6
Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.长效哌醋甲酯可降低患有注意缺陷多动障碍的年轻成年司机的碰撞率。
J Clin Psychopharmacol. 2012 Apr;32(2):225-30. doi: 10.1097/JCP.0b013e3182496dc5.
7
Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial.兴奋剂药物对患有注意力缺陷多动障碍的年轻人驾驶性能的影响:一项初步双盲安慰剂对照试验。
J Nerv Ment Dis. 2000 Apr;188(4):230-4. doi: 10.1097/00005053-200004000-00006.
8
Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.哌甲酯可提高基线能力较差的成年人的认知表现,无论其是否被诊断为注意力缺陷多动障碍。
J Clin Psychopharmacol. 2014 Apr;34(2):261-5. doi: 10.1097/JCP.0000000000000076.
9
Rebound effects with long-acting amphetamine or methylphenidate stimulant medication preparations among adolescent male drivers with attention-deficit/hyperactivity disorder.患有注意力缺陷/多动障碍的青少年男性驾驶员使用长效苯丙胺或哌甲酯兴奋剂药物制剂时的反弹效应。
J Child Adolesc Psychopharmacol. 2008 Feb;18(1):1-10. doi: 10.1089/cap.2006.0141.
10
The interactive effects of test-retest and methylphenidate administration on cognitive performance in youth with ADHD: A double-blind placebo-controlled crossover study.注意-多动障碍(ADHD)青少年中测试-重测和哌醋甲酯给药对认知表现的交互影响:一项双盲安慰剂对照交叉研究。
Psychiatry Res. 2020 Sep;291:113056. doi: 10.1016/j.psychres.2020.113056. Epub 2020 May 15.

引用本文的文献

1
Adult ADHD screening scores and hospitalization due to pedestrian injuries: a case-control study.成人注意缺陷多动障碍筛查评分与行人伤害住院治疗:一项病例对照研究。
BMC Psychiatry. 2020 Sep 10;20(1):444. doi: 10.1186/s12888-020-02848-x.
2
Validating lane drifts as a predictive measure of drug or sleepiness induced driving impairment.验证车道偏离作为预测药物或困倦引起的驾驶障碍的指标。
Psychopharmacology (Berl). 2020 Mar;237(3):877-886. doi: 10.1007/s00213-019-05424-8. Epub 2020 Jan 3.